List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 35 studies with search of: ( recurrent [CONDITION] OR relapsed [CONDITION] ) | aggressive lymphoma
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Zevalin Twice in Aggressive Non-Hodgkin Lymphoma
Condition: Relapsed/Refractory Aggressive Lymphoma
Intervention: Other: radioimmunotherapy
2 Completed Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Genetic: comparative genomic hybridization;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene rearrangement analysis
3 Active, not recruiting Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Conditions: Lymphoblastic Leukemia;   Lymphoma
Intervention: Drug: Depocyte®
4 Recruiting BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: ixabepilone
5 Active, not recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cisplatin;   Drug: cytarabine;   Drug: methylprednisolone;   Drug: pixantrone dimaleate
6 Active, not recruiting Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cisplatin;   Drug: cytarabine;   Drug: methylprednisolone;   Drug: pixantrone dimaleate;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
7 Active, not recruiting Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt
Condition: Adult Acute Lymphocytic Leukemia
Interventions: Drug: Depocyt;   Drug: Dexamethasone
8 Recruiting Phase 1 Study of Radiosensitization Using Bortezomib for Relapsed Mantle Cell or Aggressive Lymphoma Patients in Radioimmunotherapy
Condition: Lymphoma
Interventions: Drug: Velcade (bortezomib);   Drug: Bexxar (tositumomab)
9 Completed Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: oblimersen sodium;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide
10 Completed Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Biological: bevacizumab
11 Recruiting Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cisplatin;   Drug: cytarabine;   Drug: dexamethasone;   Drug: gemcitabine hydrochloride;   Other: clinical observation
12 Completed 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: pralatrexate
13 Active, not recruiting Pixantrone or Other Chemotherapy Drugs in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: etoposide;   Drug: ifosfamide;   Drug: mitoxantrone hydrochloride;   Drug: oxaliplatin;   Drug: pixantrone dimaleate;   Drug: vinorelbine ditartrate
14 Active, not recruiting Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
Condition: Lymphoma
Intervention: Radiation: radiation therapy
15 Active, not recruiting Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: vincristine sulfate liposomes
16 Completed Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: sorafenib tosylate
17 Recruiting Phase II Study of Ofatumumab Plus ICE or DHAP Chemotherapy Regimen in Relapsed/ Refractory DLBCL
Conditions: Diffuse Large B Cell Lymphoma (DLBCL);   Non-Hodgkin's Lymphoma;   Grade 3b Follicular Lymphoma;   Transformed Follicular Lymphoma
Interventions: Drug: ofatumumab + DHAP;   Drug: ofatumumab + ICE
18 Recruiting Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas
Condition: B-Cell Diffuse Large Cell Non Hodgkin's Lymphoma
Interventions: Drug: rituximab;   Drug: navelbine;   Drug: ifosfamide;   Drug: Mitoxantrone;   Drug: Prednisone
19 Terminated A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Filgrastim SD/01;   Drug: Paclitaxel;   Drug: Topotecan
20 Active, not recruiting Sorafenib in Treating Patients With Recurrent Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Drug: sorafenib tosylate

Previous Page Studies Shown (1-20) Next Page (21-35)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services